| Q35611503 | A decade's studies on metastasis of hepatocellular carcinoma |
| Q35701281 | Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectives |
| Q35165648 | Clinical significance of angiogenesis in gastrointestinal cancers: a target for novel prognostic and therapeutic approaches |
| Q30490554 | Diagnosis of hepatocellular carcinoma. |
| Q37434424 | Expression and clinical significance of angiotensin II type 1 receptor in human hepatocellular carcinoma |
| Q44606862 | Expression of angiogenic factors in hepatocellular carcinoma after transcatheter arterial chemoembolization |
| Q36065624 | Expression of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma and effect of transcatheter arterial chemoembolization therapy on plasma vascular endothelial growth factor level |
| Q34512068 | Hepatocellular carcinoma--cause, treatment and metastasis |
| Q45924805 | High expressions of vascular endothelial growth factor and platelet-derived endothelial cell growth factor predict poor prognosis in alpha-fetoprotein-negative hepatocellular carcinoma patients after curative resection. |
| Q48355658 | Mechanism of interferon alpha on inhibition of metastasis and angiogenesis of hepatocellular carcinoma after curative resection in nude mice |
| Q26851211 | Novel aspects of the liver microenvironment in hepatocellular carcinoma pathogenesis and development |
| Q36631855 | Post-collection, pre-measurement variables affecting VEGF levels in urine biospecimens |
| Q57763692 | Prognostic factors for portal venous invasion in patients with hepatocellular carcinoma |
| Q54782190 | Protein expression profiling of vascular endothelial growth factor and its receptors identifies subclasses of hepatocellular carcinoma and predicts survival. |
| Q35810123 | Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature |
| Q37706763 | Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications |
| Q42727235 | Serum vascular endothelial growth factor level in patients with hepatocellular carcinoma undergoing liver transplantation: experience of a single Western center |
| Q36710952 | TLR4 signaling promotes a COX-2/PGE2/STAT3 positive feedback loop in hepatocellular carcinoma (HCC) cells |
| Q34668320 | The prognostic molecular markers in hepatocellular carcinoma |
| Q36316676 | Theoretical basis of a beneficial role for vitamin D in viral hepatitis |
| Q39143305 | Tumor Microenvironment, a Paradigm in Hepatocellular Carcinoma Progression and Therapy |